Literature DB >> 11422451

VR1 protein expression increases in undamaged DRG neurons after partial nerve injury.

L J Hudson1, S Bevan, G Wotherspoon, C Gentry, A Fox, J Winter.   

Abstract

Changes in phenotype or connectivity of primary afferent neurons following peripheral nerve injury may contribute to the hyperalgesia and allodynia associated with neuropathic pain conditions. Although earlier studies using partial nerve injury models have focused on the role of damaged fibres in the generation of ectopic discharges and pain, it is now thought that remaining undamaged fibres may be equally important. We have examined the expression of the sensory neuron-specific cation channel Vanilloid Receptor 1 (VR1), an important transducer of noxious stimuli, in three models of nerve injury in the rat, using anatomical separation or fluorescent retrograde tracers to identify damaged or undamaged sensory neurons. After total or partial sciatic nerve transection, or spinal nerve ligation, VR1-immunoreactivity (IR) was significantly reduced in the somata of all damaged dorsal root ganglion (DRG) neuronal profiles, compared to controls. However, after partial transection or spinal nerve ligation, VR1 expression was greater in the undamaged DRG somata than in controls. Unexpectedly, after L5 spinal nerve ligation, VR1-IR of the A-fibre somata increased approximately 3-fold in the uninjured L4 DRG compared to controls; a much greater increase than seen in the somata with C-fibres. Furthermore, we found that VR1-IR persisted in the transected sciatic nerve proximal to the lesion, despite its down-regulation in the damaged neuronal somata. This persistence in the nerve proximal to the lesion after nerve section, together with increased VR1 in DRG neurons left undamaged after partial nerve injury, may be crucial to the development or maintenance of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422451     DOI: 10.1046/j.0953-816x.2001.01591.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  91 in total

Review 1.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

2.  Activity-dependent slowing of conduction velocity in uninjured L4 C fibers increases after an L5 spinal nerve injury in the rat.

Authors:  Beom Shim; Matthias Ringkamp; George L Lambrinos; Timothy V Hartke; John W Griffin; Richard A Meyer
Journal:  Pain       Date:  2006-10-06       Impact factor: 6.961

3.  A novel method to quantify histochemical changes throughout the mediolateral axis of the substantia gelatinosa after spared nerve injury: characterization with TRPV1 and substance P.

Authors:  Gregory Corder; Andrew Siegel; Allison B Intondi; Xing Zhang; James E Zadina; Bradley K Taylor
Journal:  J Pain       Date:  2010-04       Impact factor: 5.820

4.  Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury.

Authors:  Takashi Hirai; Mitsuhiro Enomoto; Hidetoshi Kaburagi; Shinichi Sotome; Kie Yoshida-Tanaka; Madoka Ukegawa; Hiroya Kuwahara; Mariko Yamamoto; Mio Tajiri; Haruka Miyata; Yukihiko Hirai; Makoto Tominaga; Kenichi Shinomiya; Hidehiro Mizusawa; Atsushi Okawa; Takanori Yokota
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

Review 5.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

6.  Spinal nerve ligation in mouse upregulates TRPV1 heat function in injured IB4-positive nociceptors.

Authors:  Daniel Vilceanu; Prisca Honore; Quinn H Hogan; Cheryl L Stucky
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

7.  Depletion of calcium stores in injured sensory neurons: anatomic and functional correlates.

Authors:  Geza Gemes; Marcel Rigaud; Paul D Weyker; Stephen E Abram; Dorothee Weihrauch; Mark Poroli; Vasiliki Zoga; Quinn H Hogan
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

8.  Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain.

Authors:  Yu Shin Kim; Yuxia Chu; Liang Han; Man Li; Zhe Li; Pamela Colleen LaVinka; Shuohao Sun; Zongxiang Tang; Kyoungsook Park; Michael J Caterina; Ke Ren; Ronald Dubner; Feng Wei; Xinzhong Dong
Journal:  Neuron       Date:  2014-01-23       Impact factor: 17.173

9.  Sensitization of cutaneous nociceptors after nerve transection and regeneration: possible role of target-derived neurotrophic factor signaling.

Authors:  Michael P Jankowski; Jeffrey J Lawson; Sabrina L McIlwrath; Kristofer K Rau; Collene E Anderson; Kathryn M Albers; H Richard Koerber
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.